The Journal of Clinical Pharmacology

Cover image for The Journal of Clinical Pharmacology

September 2012

Volume 52, Issue 9

Pages NP4–NP5, 1296–1449

  1. Corrigendum

    1. Top of page
    2. Corrigendum
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacodynamics
    6. Special Populations
    7. Drug Interactions
    8. Brief Report
    9. Letter to the Editor
    1. You have free access to this content
      Corrigendum (pages NP4–NP5)

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270012460027

  2. Pharmacokinetics and Pharmacodynamics

    1. Top of page
    2. Corrigendum
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacodynamics
    6. Special Populations
    7. Drug Interactions
    8. Brief Report
    9. Letter to the Editor
    1. Enhanced Sensitivity to Drug-Induced QT Interval Lengthening in Patients With Heart Failure Due to Left Ventricular Systolic Dysfunction (pages 1296–1305)

      James E. Tisdale, Brian R. Overholser, Heather A. Wroblewski, Kevin M. Sowinski, Kwadwo Amankwa, Steven Borzak, Joanna R. Kingery, Rita Coram, Douglas P. Zipes, David A. Flockhart and Richard J. Kovacs

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270011416939

    2. Pharmacokinetics and Pharmacodynamics of MK-5046, a Bombesin Receptor Subtype-3 (BRS-3) Agonist, in Healthy Patients (pages 1306–1316)

      Marc L. Reitman, Victor Dishy, Allison Moreau, William S. Denney, Chengcheng Liu, Walter K. Kraft, Alex V. Mejia, Mark A. Matson, S. Aubrey Stoch, John A. Wagner and Eseng Lai

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270011419854

  3. Pharmacokinetics

    1. Top of page
    2. Corrigendum
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacodynamics
    6. Special Populations
    7. Drug Interactions
    8. Brief Report
    9. Letter to the Editor
    1. Meclizine Metabolism and Pharmacokinetics: Formulation on Its Absorption (pages 1343–1349)

      Zhijun Wang, Benjamin Lee, Daniel Pearce, Shuai Qian, Yanfeng Wang, Qizhi Zhang and Moses S. S. Chow

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270011414575

    2. Food Increased the Bioavailability of BMS-690514, an Orally Active EGFR/HER2/VEGF Receptor Kinase Inhibitor, in Healthy Subjects (pages 1350–1356)

      Blisse Vakkalagadda, Jong-Soon Park, Christoph M. Ahlers, Stephanie Dorizio, Teresa Has, Vikram Roongta, Kevin N. Heller, George M. Derbin and Steven Zhang

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270011417826

  4. Pharmacodynamics

    1. Top of page
    2. Corrigendum
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacodynamics
    6. Special Populations
    7. Drug Interactions
    8. Brief Report
    9. Letter to the Editor
    1. Impact of Sildenafil on Survival of Patients With Idiopathic Pulmonary Arterial Hypertension (pages 1357–1364)

      Wei-Jie Zeng, Yun-Juan Sun, Qing Gu, Chang-Ming Xiong, Jian-Jun Li and Jian-Guo He

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270011418656

    2. The Effects of N-Acetylcysteine and Deferoxamine on Plasma Cytokine and Oxidative Damage Parameters in Critically Ill Patients With Prolonged Hypotension: A Randomized Controlled Trial (pages 1365–1372)

      Cassiana Mazon Fraga, Cristiane Damiani Tomasi, Daiane Biff, Maria Fernanda Locks Topanotti, Francine Felisberto, Francieli Vuolo, Fabricia Petronilho, Felipe Dal-Pizzol and Cristiane Ritter

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270011418657

  5. Special Populations

    1. Top of page
    2. Corrigendum
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacodynamics
    6. Special Populations
    7. Drug Interactions
    8. Brief Report
    9. Letter to the Editor
    1. Dabigatran Etexilate in Atrial Fibrillation Patients With Severe Renal Impairment: Dose Identification Using Pharmacokinetic Modeling and Simulation (pages 1373–1378)

      Thorsten Lehr, Sebastian Haertter, Karl-Heinz Liesenfeld, Alexander Staab, Andreas Clemens, Paul A. Reilly and Jeffrey Friedman

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270011417716

    2. Tigecycline Pharmacokinetics in Subjects With Various Degrees of Renal Function (pages 1379–1387)

      Joan M. Korth-Bradley, Steven M. Troy, Kyle Matschke, Gopal Muralidharan, Richard J. Fruncillo, John L. Speth and Donald G. Raible

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270011416938

  6. Drug Interactions

    1. Top of page
    2. Corrigendum
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacodynamics
    6. Special Populations
    7. Drug Interactions
    8. Brief Report
    9. Letter to the Editor
    1. Investigation of a Possible Interaction Between Quetiapine and Armodafinil in Patients With Schizophrenia: An Open-Label, Multiple-Dose Study (pages 1399–1409)

      Mona Darwish, Mary Bond, Edward T. Hellriegel, James M. Youakim, Ronghua Yang and Philmore Robertson Jr

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270011414572

    2. Absence of Pharmacokinetic Interaction Between Intravenous Peramivir and Oral Oseltamivir or Rimantadine in Humans (pages 1410–1419)

      George Atiee, Kenneth Lasseter, Sharon Baughman, Amy McCullough, Phil Collis, Alan Hollister and Jaime Hernandez

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270011414574

    3. Effect of Carisbamate on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Participants (pages 1420–1429)

      Martha Gonzalez, Peter Zannikos, Allitia DiBernardo, H. Robert Brashear and Jay Ariyawansa

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270011415412

  7. Brief Report

    1. Top of page
    2. Corrigendum
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacodynamics
    6. Special Populations
    7. Drug Interactions
    8. Brief Report
    9. Letter to the Editor
    1. Linezolid Pharmacokinetics in Patients With Acute Renal Failure Undergoing Continuous Venovenous Hemodiafiltration (pages 1430–1435)

      Esther Carcelero, Dolors Soy, Laura Guerrero, Esteban Poch, Javier Fernandez, Pedro Castro and Jose Ribas

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270011417717

    2. Long-Term Therapy With Thalidomide in Hereditary Hemorrhagic Telangiectasia: Case Report and Literature Review (pages 1436–1440)

      Chih-Hsuan Chen, Hsao-Hsun Hsu, Rey-Heng Hu, Po-Huang Lee and Cheng-Maw Ho

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270011417824

    3. Bupivacaine Extended Release Liposome Injection Does Not Prolong QTc Interval in a Thorough QT/QTc Study in Healthy Volunteers (pages 1441–1447)

      Asif Naseem, Tomohiko Harada, Duolao Wang, Radivoj Arezina, Ulrike Lorch, Erol Onel, Alan John Camm and Jorg Taubel

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270011419853

  8. Letter to the Editor

    1. Top of page
    2. Corrigendum
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacodynamics
    6. Special Populations
    7. Drug Interactions
    8. Brief Report
    9. Letter to the Editor
    1. Aripiprazole Associated With Acute Dystonia, Akathisia, and Parkinsonism in a Single Patient (pages 1448–1449)

      Sahoo Saddichha, Ram Kumar, Girish N. Babu and Prabha Chandra

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270011414573

SEARCH

SEARCH BY CITATION